NYSEAMERICAN:BVX Bovie Medical (BVX) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free BVX Stock Alerts $6.48 +0.07 (+1.09%) (As of 12/31/2018) Add Compare Share Share Today's Range$6.35▼$6.7150-Day Range N/A52-Week Range$2.28▼$7.70Volume129,500 shsAverage Volume136,878 shsMarket Capitalization$215.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bovie Medical alerts: Email Address Ad Behind the MarketsThe AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> About Bovie Medical Stock (NYSEAMERICAN:BVX)Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.Read More BVX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BVX Stock News HeadlinesMarch 21, 2024 | americanbankingnews.comBovie Medical (NYSEAMERICAN:BVX) Stock Passes Above 50-Day Moving Average of $0.00April 21, 2023 | marketwatch.com2023-2030 Medical Smoke Evacuation System Market Size with [113 Pages] includes Recent Developments | New Report by Absolute ReportsMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.March 17, 2023 | markets.businessinsider.comBovie Medical earnings: here's what Wall Street expectsJanuary 22, 2023 | finance.yahoo.comElectrosurgical Devices Global Market Report 2022: Featuring Olympus, Bovie Medical, ATMOS, Johnson and Johnson & MoreJanuary 11, 2023 | thestreet.comBovie Medical Corporation (BVX): Today's Featured Health Care LoserOctober 16, 2022 | washingtonpost.comMEDICAL MYSTERIESOctober 26, 2021 | finance.yahoo.comBovie Medical (BVX) Looks Good: Stock Moves 9.1% HigherSee More Headlines Receive BVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bovie Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2018Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolNYSEAMERICAN:BVX Previous SymbolAMEX:BVX CUSIPN/A CIK719135 Webwww.boviemedical.com Phone(727) 384-2323FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares33,200,000Free FloatN/AMarket Cap$215.14 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesCharles D. GoodwinPresident, Chief Executive Officer & DirectorMatthew C. HillChief Financial & Accounting OfficerShawn D. RomanDirector-Research & DevelopmentKari LarsonSenior Director-Clinical AffairsTodd HornsbyExecutive Vice PresidentKey CompetitorsAngioDynamicsNASDAQ:ANGOINmune BioNASDAQ:INMBMerrimack PharmaceuticalsNASDAQ:MACKCompugenNASDAQ:CGENOptheaNASDAQ:OPTView All Competitors BVX Stock Analysis - Frequently Asked Questions How were Bovie Medical's earnings last quarter? Bovie Medical Co. (NYSEAMERICAN:BVX) announced its quarterly earnings results on Thursday, November, 1st. The medical device company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.08. The medical device company had revenue of $3.67 million for the quarter, compared to the consensus estimate of $3.67 million. The company's quarterly revenue was up 38.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.09) earnings per share. What other stocks do shareholders of Bovie Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), A.H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS), Ceragon Networks (CRNT) and Genetic Technologies (GENE). How do I buy shares of Bovie Medical? Shares of BVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:BVX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bovie Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.